NEW YORK (GenomeWeb News) – Roche business Ventana today announced a companion diagnostic development deal for a Genmab antibody drug conjugate program.

Ventana will develop an immunohistochemistry CDx test for detecting tissue factor in patient tumor samples with the intent that the assay could be used as the screening test in clinical trials for Genmab's HuMax-TF-ADC, Ventana said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.